Samrat Pharmachem Limited (BOM:530125)
India
· Delayed Price · Currency is INR 211.50
+1.55 (0.74%)
At close: Apr 28, 2026
Samrat Pharmachem Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 27, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 649 | 966 | 1,030 | 1,147 | 1,498 | 420 | Upgrade
|
| Market Cap Growth | -33.46% | -6.21% | -10.15% | -23.45% | 256.47% | 127.05% | Upgrade
|
| Enterprise Value | 565 | 986 | 1,227 | 1,324 | 1,530 | 451 | Upgrade
|
| Last Close Price | 210.20 | 311.79 | 331.90 | 368.45 | 480.90 | 134.91 | Upgrade
|
| PE Ratio | - | 13.59 | 47.64 | 6.89 | 8.72 | 7.88 | Upgrade
|
| PS Ratio | 0.22 | 0.34 | 0.37 | 0.37 | 0.68 | 0.24 | Upgrade
|
| PB Ratio | 0.92 | 1.35 | 1.59 | 1.82 | 3.20 | 1.42 | Upgrade
|
| P/TBV Ratio | 0.92 | 1.35 | 1.59 | 1.82 | 3.20 | 1.42 | Upgrade
|
| P/FCF Ratio | - | - | 11.78 | - | 9.25 | 20.31 | Upgrade
|
| P/OCF Ratio | - | - | 10.95 | - | 8.57 | 8.76 | Upgrade
|
| EV/Sales Ratio | 0.20 | 0.35 | 0.44 | 0.43 | 0.69 | 0.25 | Upgrade
|
| EV/EBITDA Ratio | - | 9.47 | 48.85 | 5.51 | 6.28 | 4.98 | Upgrade
|
| EV/EBIT Ratio | - | 10.11 | 65.76 | 5.66 | 6.43 | 5.27 | Upgrade
|
| EV/FCF Ratio | - | - | 14.03 | - | 9.45 | 21.78 | Upgrade
|
| Debt / Equity Ratio | 0.16 | 0.14 | 0.13 | 0.30 | 0.16 | 0.30 | Upgrade
|
| Debt / EBITDA Ratio | - | 0.95 | 3.37 | 0.78 | 0.31 | 0.97 | Upgrade
|
| Debt / FCF Ratio | - | - | 0.97 | - | 0.46 | 4.25 | Upgrade
|
| Net Debt / Equity Ratio | -0.12 | 0.13 | -0.02 | 0.11 | -0.15 | 0.21 | Upgrade
|
| Net Debt / EBITDA Ratio | 13.20 | 0.91 | -0.49 | 0.28 | -0.29 | 0.70 | Upgrade
|
| Net Debt / FCF Ratio | - | -0.90 | -0.14 | -0.62 | -0.44 | 3.04 | Upgrade
|
| Asset Turnover | - | 2.35 | 2.36 | 3.09 | 3.13 | 3.10 | Upgrade
|
| Inventory Turnover | - | 9.09 | 10.16 | 12.37 | 15.95 | 10.89 | Upgrade
|
| Quick Ratio | - | 1.15 | 1.40 | 1.20 | 1.56 | 1.31 | Upgrade
|
| Current Ratio | - | 2.09 | 1.82 | 1.86 | 1.91 | 1.73 | Upgrade
|
| Return on Equity (ROE) | - | 10.40% | 3.38% | 30.25% | 44.95% | 19.77% | Upgrade
|
| Return on Assets (ROA) | - | 5.01% | 0.98% | 14.53% | 20.93% | 9.23% | Upgrade
|
| Return on Invested Capital (ROIC) | -2.08% | 9.67% | 2.40% | 31.51% | 45.83% | 18.14% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 13.60% | 2.90% | 36.90% | 50.30% | 28.40% | Upgrade
|
| Earnings Yield | -2.58% | 7.36% | 2.10% | 14.50% | 11.47% | 12.69% | Upgrade
|
| FCF Yield | - | -10.97% | 8.49% | -9.50% | 10.81% | 4.92% | Upgrade
|
| Dividend Yield | 0.47% | 0.32% | 0.30% | 0.27% | 0.21% | - | Upgrade
|
| Payout Ratio | - | 4.35% | 14.29% | 1.86% | - | - | Upgrade
|
| Total Shareholder Return | 0.40% | 0.32% | 0.30% | 0.27% | 0.21% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.